Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

RANI

+ Watchlist+ Portfolio

Rani Therapeutics Holdings, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.56
52-Week Range
$0.50 – $1.91
Market Cap
$74.85M
P/E (TTM)
—
EPS (TTM)
-0.07
Dividend Yield
0.00%
Advanced Metrics
Price/Book
2.20
PEG Ratio
—
Return on Equity
-233.59%
Return on Assets
-69.66%
Gross Margin
100.00%
Operating Margin
-530.45%
Profit Margin
0.00%
Current Ratio
5.26
Debt/Equity
0.08
Total Debt
$3.15M
Free Cash Flow
$-11.65M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$40.09M

Market Snapshot

About

Rani Therapeutics Holdings, Inc. develops an oral delivery platform using a robotic pill technology that enables biologics to be taken orally instead of through injections, targeting chronic conditions like osteoporosis and inflammatory diseases.